Skip to main content
. 2022 Mar 14;29(1):889–905. doi: 10.1080/10717544.2022.2050845

Figure 1.

Figure 1.

Characterization of the (DTXL + siRNA)@NPs or (DTXL + siRNA)@NPs-ALN nanoparticles. (A) Size distribution of (DTXL + siRNA)@NPs nanoparticle. (B) Transmission electron microscopy (TEM) images of (DTXL + siRNA)@NPs nanoparticle. (C) Size distribution of (DTXL + siRNA)@NPs-ALN nanoparticle. (D) Transmission electron microscopy (TEM) images of (DTXL + siRNA)@NPs-ALN nanoparticle. (E) Zeta potential of (DTXL + siRNA)@NPs and (DTXL + siRNA)@NPs-ALN nanoparticle. (F) FTIR spectra of DOPE-PEG and DOPE-PEG-ALN. (G) The encapsulation capability of (DTXL + siRNA)@NPs-ALN for siRNA using a gel-retardation assay, green arrow indicated the free siRNA and blue arrow indicated the siRNA@NPs.